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Background: Hydrocephalus is a central nervous system (CNS) disorder characterized by the abnormal
accumulation of cerebrospinal fluid (CSF) in cerebral ventricles, resulting in their dilatation and associated brain
tissue injury. The pathogenesis of hydrocephalus remains unclear; however, recent reports suggest the possible
involvement of abnormal osmotic gradients. Here we explore the kinetics associated with manipulating CSF
osmolarity on ventricle volume (VV) in the normal rat brain.
Methods: CSF was made hyper-osmotic by introducing 10KD dextran into the lateral ventricle, either by acute
injection at different concentrations or by chronic infusion at a single concentration. The induction and withdrawal
kinetics of dextran infusion on VV were explored in both contexts.
Results: Acute intraventricular injection of dextran caused a rapid increase in VV which completely reversed within
24 hours. These kinetics are seemingly independent of CSF osmolarity across a range spanning an order of
magnitude; however, the magnitude of the transient increase in VV was proportional to CSF osmolarity. By contrast,
continuous intraventricular infusion of dextran at a relatively low concentration caused a more gradual increase in
VV which was very slow to reverse when infusion was suspended after five days.
Conclusion: We conclude that hyperosmolar CSF is sufficient to produce a proportional degree of hydrocephalus
in the normal rat brain, and that this phenomenon exhibits hysteresis if CSF hyperosmolarity is persistent. Thus
pathologically-induced increases in CSF osmolarity may be similarly associated with certain forms of clinical
hydrocephalus. An improved understanding of this phenomenon and its kinetics may facilitate the development of
novel therapies for the treatment of clinical hydrocephalus.
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Hydrocephalus is a CNS disorder characterized by the
abnormal accumulation of cerebrospinal fluid (CSF) in
cerebral ventricles and increased ventricle volume (VV).
The pathogenesis underlying the emergence of hydroce-
phalus is poorly understood [1-5] and remains an unre-
solved issue despite many years of investigation [6-10].
Clinical hydrocephalus is commonly classified based on
symptomatology as either obstructive hydrocephalus,
communicating hydrocephalus, or normal pressure
hydrocephalus (NPH). Classically, hydrocephalus is
thought to reflect either a blockage of CSF circulation
within the ventricles and/or impaired CSF absorption* Correspondence: krishnsa@upstate.edu
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distribution, and reproduction in any mediumthrough the arachnoid projections into the cranial
venous sinuses or nasal lymphatics [11-19]. However,
clinical hydrocephalus routinely manifests without any
detectable blockage of CSF circulation pathways [20-24],
and several reports have cast doubt on the role of ara-
chnoid projections in this context [25-27].
The classical view regarding the etiology of hydroce-
phalus is further challenged by recent reports that
chronically increased CSF osmolarity is sufficient to pro-
duce hydrocephalus in the normal rat or dog brain [28-
31]. It has been proposed that hydrocephalus in this con-
text reflects a disparity between the relatively free move-
ment of water within brain tissues (including the
ventricles), made possible by the presence of aquaporins,
and the strictly regulated movement of hydrophilic
macromolecules across the blood–brain barrier (BBB)Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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parity, artificially increasing CSF osmolarity by infusing
hydrophilic macromolecules creates an osmotic gradient
which draws water into the ventricles.
Here we investigate the kinetics of hydrocephalus fol-
lowing the injection/infusion of 10KD dextran into the
lateral ventricle in the normal rat brain. Our results lend
additional support to the hypothesis that osmotic effects
are sufficient to induce hydrocephalus and reveal that
the associated kinetics can have a dramatic effect on the
nature and persistence of the hydrocephalic response.
Materials and methods
Subjects
Adult female Sprague–Dawley rats (220-250 g, n = 84;
Harlan, Indianapolis, Indiana, USA) were used in all
experiments. Rats were housed in an AAALAC-
accredited animal care facility at Wayne State University
and maintained on a 12-h light/dark cycle with food and
water provided ad libitum. Animal procedures were car-
ried out in accordance with NIH guidelines for the care
and use of experimental animals and the experimental
protocol was approved by the Institutional Animal Care
and Use Committee at Wayne State University in
Detroit, Michigan.
Experiment 1: Acute intraventricular injection (n = 45)
For this experiment, rats were randomly divided into five
groups which received acute injections (15μl) of FITC-
labeled dextran (10KD) into the lateral ventricle at different
osmolarities via a Hamilton syringe. Group I (337 mOsm/L,
n=10), Group II (628 mOsm/L, n=10), Group III
(977 mOsm/L, n=9), Group IV (2000 mOsm/L, n=8) and
Group V (3347 mOsm/L, n=8). Ventricle volumes were
assayed by volumetric analysis of MRI image data obtained
from scans performed prior to injecting hyperosmotic dex-
tran solution, at 30 minutes post-injection, and at 24 hours
post-injection.
One-time lateral ventricle injection (acute experiment)
Rats were anesthetized with Ketamine (87 mg/kg, intra-
peritoneally or i.p.) and Xylazine (13 mg/kg, i.p.) and
mounted in an animal stereotactic instrument (Kopf).
Using aseptic techniques, 15 μl of fluorescently-labeled
10KD dextran solution (1 μg/μl) was injected (1 μl/s)
into the frontal horn of the right lateral ventricle using a
Hamilton syringe connected to a stainless steel needle
(27 gauge, blunt tip). The needle was inserted through a
burr hole positioned 0.9 mm posterior, 1.2 mm lateral to
bregma, and lowered perpendicular to the cranial sur-
face to a depth of 3.6 mm ventral to the dorsal surface
of the dura mater [32]. After injection, the needle was
held in place for 1 minute and then slowly withdrawn.The burr hole was then sealed with bone wax and the
incision was sutured closed.
Experiment 2: Chronic intraventricular infusion (n = 39)
For this experiment, rats were randomly divided into 4
groups defined by their intraventricular infusion status
(On/Off) during three consecutive 5-day intervals (A, B,
C). Groups I and II: On-On-On (n= 10 for both groups);
Group III: On-Off-On (n= 9); Group IV: On-Off-Off
(n= 10). During ‘On’ intervals, rats received intraventricu-
lar infusion at a rate of 0.5 μl/hr with either iso-osmotic
(307 mOsm/L; Group I) or hyper-osmotic (337 mOsm/L;
Groups II, III, and IV) FITC-labeled dextran (10KD).
During ‘Off ’ intervals, intraventricular infusion of dex-
tran was suspended with the cannula in place. Pumps
were On during interval A for all groups. The infusion
status was changed (Groups III and IV) at the begin-
ning of interval B, and again (Group III) at the begin-
ning of interval C. For each of these procedures, rats
were anesthetized with ketamine (87 mg/kg, i.p.) and
xylazine (13 mg/kg, i.p.) and a 1.0 cm incision was
made on the dorsal surface of the neck to expose the
catheter, which was either closed by ligating (‘Off ’ con-
dition) or open by unligating (‘On’ condition) the cathe-
ter using 3–0 silk suture. The efficacy and reversibility
of this ligation procedure in this context was verified in
preliminary experiments. Sham procedures were per-
formed for groups where the catheter remained open
during intervals A, B and C (Groups I and II). MRI
scans were performed prior to pump implantation
(baseline) and at the end of each interval to assay ven-
tricular volumes.
Osmotic pump implantation
Rats were anesthetized with ketamine (87 mg/kg, i.p.)
and xylazine (13 mg/kg, i.p.) and mounted in an animal
stereotactic instrument (Kopf). Using aseptic techniques,
a midline incision was made and the dorsal surface of the
skull was exposed completely. A blunt tip 27-gauge nee-
dle was inserted through a burr hole positioned 0.9 mm
posterior, 1.2 mm lateral to bregma, and lowered perpen-
dicular to the cranial surface to a depth of 3.6 mm ven-
tral to the dorsal surface of the dura mater, placing the
tip of the needle in the ventral horn of the lateral ventri-
cle [32]. The needle was slowly withdrawn and replaced
with a customized microcatheter of equivalent diameter
connected to an Alzet osmotic minipump primed with
approximately 230 μl of dextran solution (0.083 μg/μl)
(Model 2002, DURECT Corporation, Cupertino, CA,
USA). The microcatheter was positioned within a shal-
low groove created on the surface of the cranial bone,
extending 3 mm posterior to the burr hole, and cemen-
ted in place using Surgicel (ETHICON, Inc., Somerville,
NJ, USA) with cyanoacrylate adhesive (DURECT
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subcutaneous pocket in the mid-scapular region and the
incision was sutured closed.
MRI imaging and ventricular volume calculation
Whole head MRI images were acquired under Ketamine
(87 mg/kg, i.p.) and Xylazine (13 mg/kg, i.p.) anesthesia
in the 7-Tesla MRI System (ClinScan, Bruker, Karlsruhe,
Germany) at the Magnetic Resonance Research Facility
at Wayne State University. For the Experiment 1, MRI
scans were performed prior to injection and at 30 min-
utes and 24 hours post-injection. For experiment 2, MRI
scans were performed prior to cannula implantation and
at 5, 10 and 15 days post-implantation, immediately
prior to initiating surgical procedures to change infusion
status. Coronal axial T2-weighted images were acquired
using the following parameters: TR 3.53 sec, TE 38 ms,
FOV 32x32mm2, matrix size 256x256, 1 signal average,
1 mm slice thickness, interleaved 24 slices, TA 2 m.
Regions of interest (ROI) for all transverse slices were
manually outlined and the surface area determined by
counting the number of pixels enclosed by the ROI. Seg-
mental volumes were calculated by multiplying slice
areas by slice thickness, and total T2-weighted MRI
volumes were determined by summing the segmental
volumes. Internally developed MR SPIN (Signal Proces-
sing in NMR) software (MRI Institute for Biomedical
Research, Detroit, MI, USA) written in Visual C++ on
the Microsoft Windows platform was used for MRI and
ventricular volume calculation [33]. Animals that died
during the experiment were not included in the analysis.
Statistical methods
For Experiment 1, descriptive statistics of mean, median
and standard deviation were computed for each of the
five treatments groups (337, 628, 977, 2000, and
3347 mOsm/L) at each of the three time-points (pre-,Table 1 Non-normalized mean ventricle volumes for Experim
Experiment 1 Pre-Injection ± SD (μm3) 30
Pos
337mOsm/L (n=10) 16.69 ± 2.2 18
628mOsm/L (n=10) 16.42 ± 1.37 19.0
977mOsm/L (n=9) 16.29 ± 1.07 19.4
2000mOsm/L (n=8) 16.17 ± 1.88 24.7
3347mOsm/L (n=8) 15.7 ± 1.78 30.8
Experiment 2 Pre-Surgery (μm3) Pum
Inte
On-Off-On (337mOsm/L, n=9) ± SD 19.16 ± 3.78 25.9
On-Off-Off (337mOsm/L, n=10) ± SD 16.63 ± 1.85 19.0
On-On-On (337mOsm/L, n=10) ± SD 14.47 ± 2.36 24.0
On-On-On (307mOsm/L, n=10) ± SD 17.23 ± 1.96 19.730 min post-, and 24hour post-injection). Because of the
wide range of variability among the groups, Wilcoxon
two sample tests were performed to assess whether the
pairwise group comparisons differed at each time-point.
Signed rank tests were done to assess the differences
over time within treatment groups. Spearman’s correla-
tion coefficients were computed between the osmolality
levels (treatment groups) and the volumes at each time
point. P-values between 0.01 and 0.05 were interpreted
as significant whereas P-values < 0.01 were considered
highly significant.
For Experiment 2, data for each rat was ‘normalized’
to individual baselines. Log transformations of the data
were performed to reduce the influence of variance asso-
ciated with group means. Descriptive statistics of mean,
median and standard deviation were computed for each
of the four treatments groups (Groups I-IV) at each of
the three time-points (A, B, C). Mixed models methods
using repeated measures were used to estimate the rate
of change over time (slope), and to test these slopes
among the four groups. P-values between 0.01 and 0.05
were interpreted as significant whereas P-values <0.01
were considered highly significant.Results
For Experiment 1 (Table 1 and Figure 1), there was a posi-
tive correlation between VV and the osmolarity of dextran
solution at 30 minutes post-injection (r2 = 0.8349,
P<0.001), which was not present pre-injection or at 24
hours post-injection. Within group comparisons of pre-
injection VVs relative to VVs at 30 min and 24 hours post-
injection revealed that VVs were significantly increased for
all groups at 30 minutes post-injection (P< 0.037), with
highly significant increases for Groups III, IV, and V
(P< 0.007); however, these increases in VV had completely
resolved by 24 hours post-injection. Between group com-
parisons of VVs at each time-point revealed that VV wasents 1 and 2
Minutes
t-Injection ± SD (μm3)
24 hours Post-Injection ± SD (μm3)
.3 ± 3.04 15.75 ± 2.12
6 ± 3.28 15.79 ± 1.56
2 ± 2.51 16.97 ± 2.38
9 ± 8.51 16.4 ± 5.26







8 ± 8.96 26.67 ± 10.35 28.63 ± 11.69
2 ± 2.55 21.7 ± 6.68 20.2 ± 3.38
9 ± 13.06 27.64 ± 12.98 32.95 ± 19.33
5 ± 4.22 20.26 ± 4.51 21.56 ± 6.02
Figure 1 Experiment 1: VV was measured 30 minutes and 24 hours following acute intraventricular injection of 10kD dextran solution
yielding a range of CSF osmolarities spanning an order of magnitude. Results are expressed as a percentage relative to normalized
VVs measured prior to ventricular injection. VVs were significantly increased for all groups at 30 minutes post-injection (P< 0.037), with highly
significant increases for Groups III (977 mOsm/L), IV (2000 mOsm/L) and V (3347 mOsm/L) (P< 0.007). These increases in VV were completely
resolved by 24 hours post-injection. Significant differences in VV between groups were not observed either pre-injection or 24 hours
post-injection. At 30 minutes post-injection, there is a positive correlation (R2 = 0.8349) between increased CSF osmolarity and VV.
(* P< 0.05, ** P< 0.01).
Figure 2 Experiment 2: VV was measured at 5 day intervals during continuous intraventricular infusion of 10kD dextran yielding CSF
osmolarities of 307 (isoosmolar) or 337 mOsm/L (hyperosmolar). Results are expressed as a percentage relative to normalized VVs measured
prior to initiating ventricular infusion. VV in Group I (On-On-On 307 mOsm/L) increased incrementally at each time-point over the course of
continuous iso-osmotic dextran infusion. VV in Group II (On-On-On 337 mOsm/L) also increased at each time-point over the course of continuous
hyper-osmotic dextran infusion; however, these increases were larger and highly significant. VV in Group III (On-Off-On 337 mOsm/L), trended
toward increase during interval A, slowed during interval B when infusion was suspended, and resumed increasing and reached significance
during interval C when infusion was restored. VV in Group IV (On-Off-Off 337 mOsm/L), trended toward increase during interval A. The rate of
increase slowed during intervals B and C when infusion was suspended but the increase in VV reached significance at both time-points.
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post-injection relative to Groups I – IV (P< 0.017), with a
trend toward increased VVs in Group IV (P <0.061).
Significant differences in VV were not observed between
groups either pre-injection or at 24 hours post-injection.
Moreover, there were no significant differences between
pre-injection VVs and VVs at 24 hours post-injection,
reflecting that fact that VVs returned to their original
pre-injection volumes by 24 hours post-injection.
For Experiment 2 (Table 1 and Figure 2), the infused
dextran solution was iso-osmotic (307 mOsm/L) for
Group I and mildly hyper-osmotic (337 mOsm/L) for
Groups II, III, and IV. VV was assayed before and at
5 day intervals after initiating dextran infusion, imme-
diately prior to manipulations of the infusion status
(On/Off). Within group comparisons revealed that,
relative to preinfusion values, VV in Group I (On-On-
On, n = 10) increased incrementally at each time-point
over the course of continuous iso-osmotic dextran
infusion (A: P < 0.044, B: P < 0.023, C: P < 0.015). VV in
Group II (On-On-On, n = 10) also increased at each
time-point over the course of continuous hyper-
osmotic dextran infusion; however, these increases wereFigure 3 Coronal T2-weighted MR images obtained from representat
Group III (977 mOsm/L), Group IV (2000 mOsm/L) and Group V (3347
(column 1), at the end of 30 mins (column 2) and at 24 hours (column 3) flarger and highly significant (A: p < 0.007, B: P < 0.001,
C: P < 0.001). VV in Group III (On-Off-On, n = 9),
trended toward increase during interval A (P < 0.069);
however, the rate of increase slowed significantly dur-
ing interval B when infusion was suspended (P < 0.061)
and resumed increasing at its original rate and reached
significance during interval C when infusion was
restored (P < 0.028). VV in Group IV (On-Off-Off,
n = 10), trended toward increase during interval A
(P < 0.081). The rate of increase slowed during intervals
B and C when infusion was suspended but the increase
in VV reached significance at both time-points (B:
P < 0.045, C: P < 0.009). Between group comparisons of
VVs at each time-point revealed that, relative to Group
I, the increase in VV in Group II was significant dur-
ing interval A (P < 0.047), and highly significant during
intervals B (P < 0.001) and C (P < 0.001). The increase
in VV in Group II, relative to Group IV, was also sig-
nificant during interval B (P < 0.017) and highly signifi-
cant during interval C (P < 0.001). MRI images
(Figure 3) revealed no evidence of obstruction or occlu-
sion of the cerebral aqueducts or other putative CSF cir-
culation pathways. Representative T2 weighted MRive animals from Group I (337 mOsm/L), Group II (628 mOsm/L),
mOsm/L) in Experiment 1. MR images were acquired pre-infusion
ollowing injection.
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presented in Figure 4.
Behavioral effects related to these manipulations of
CSF osmolarity and VV were not systematically investi-
gated; however, with the exception of transient anesthe-
sia effects, the rats appeared alert and attentive and
maintained their weight and hydration status for the
duration of the study.
Discussion
The objective of this study was to elucidate the kinetics
associated with manipulating CSF osmolarity on VV in
the normal rat brain. Our results confirm previous
reports suggesting that increasing CSF osmolarity is suf-
ficient to increase VV and include novel observations
regarding the influence of concentration and time in this
context. Transient increases of CSF osmolarity over a
range spanning an order of magnitude are sufficient to
cause acute and proportional increases in VV which arePre nO
Group I: On-On-On (307mOsm/L )
Pre On
Group II:  On-On-On (337mOsm/L)
Pre nO
Group III: On-Off-On (337mOsm/L )
Pre nO
Group IV: On-Off-Off (337mOsm/L )
Figure 4 Coronal T2-weighted MR images obtained from representat
were acquired pre-infusion (column 1), and at the end of intervals A (colum
LV: lateral ventricle.completely reversed by 24 hours post-injection. These
acute increases in VV are observed primarily within the
injected hemisphere at 30 minutes post-injection but
encompass the entire rostral-caudal extent of the brain.
Sustained increases of CSF osmolarity at the lower end
of this range result in more gradual increases in VV that
evolve bilaterally over the course of five days of continu-
ous dextran infusion and are much slower to reverse
when dextran infusion is suspended. This apparent hys-
teresis may reflect a persistent saturation of clearance
mechanisms which normally regulate CSF osmolarity
and/or ventricular volume. Collectively, our results sug-
gest that the induction and withdrawal kinetics of
increased VV are directly affected by both the magnitude
and duration of increases in CSF osmolarity.
Changes in VV produced by manipulating CSF osmo-
larity may reflect the relatively free movement of water
within brain tissues made possible by the presence of





ive animals from Groups I, II, III and IV in Experiment 2. MR images
n 2, days 1–5), B (column 3, days 6–10) and C (column 4, days 11–15).
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across the BBB in response to osmotic gradients asso-
ciated with the presence of relatively impermeable and
strictly regulated solutes. Transport of these solutes
might, therefore, be a means by which CSF osmolarity
and the volume of CSF is normally regulated within the
ventricles. Recent reports suggest that water may cycle
continuously between CSF and plasma in response to
osmotic gradients and changes in hydrostatic pressure,
as blood passes from arterial to venous microvessels [37-
39]. Consistent with this hypothesis, increases in venous
pressure have recently been shown to be sufficient to
cause an accumulation of CSF within the ventricles [37].
The rapid induction and withdrawal kinetics of VV
increases associated with transient increases in CSF
osmolarity, suggest that 10 kD dextran is rapidly and effi-
ciently cleared from CSF under these conditions. It
remains to be determined whether the associated ipsilat-
eral increase in VV observed at 30 minutes post-
injection eventually becomes bilateral or whether the rate
of clearance is sufficient to prevent this. By contrast, the
much more gradual induction and withdrawal kinetics of
VV increases induced by modest increases in CSF osmo-
larity sustained over several days were unexpected. These
may reflect a gradual saturation of endogenous transport
mechanisms which normally participate in clearing such
solutes from CSF, combined with a long post-saturation
refractory period. An analogous influx of solutes into
CSF resulting from brain tumors, cerebral trauma,
arterio-venous malformations, neurodegenerative dis-
eases and other brain pathologies might, therefore, simi-
larly saturate these putative transport mechanisms and
give rise to hydrocephalus displaying similar kinetics.
Such solutes could include ions, amino acids, neuro-
transmitters, proteins and peptides crossing the compro-
mised BBB and other cellular debris associated with
apoptotic and/or necrotic cell death.
In conclusion, our results suggest that brain patholo-
gies that compromise BBB integrity or which otherwise
promote the pathological release of cellular constituents
into interstitial fluid and/or CSF may be sufficient to
induce hydrocephalus by increasing CSF osmolarity.
Moreover, a sustained influx of these constituents at rela-
tively low concentrations and the associated increase in
CSF osmolarity may be more pathogenic than an acute
influx at higher concentrations. Therapies which prevent
or mitigate such increases in CSF osmolarity might
therefore prove useful in treating hydrocephalus. Assays
of CSF content that affects osmolarity might also prove
useful for distinguishing among types of hydrocephalus
that may be responsive to such a therapeutic approach.Competing interests
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